Efficacy of nab-paclitaxel plus trastuzumab in a long-surviving heavily pretreated HER2-positive breast cancer patient with brain metastases

Por Ricciardi, Giuseppina Rosaria Rita, Russo, Alessandro, Franchina, Tindara, Ferraro, Giuseppa, Adamo, Vincenzo
Publicado no Onco Targets Ther (2015)

Emerging Targeted Therapies for Castration-Resistant Prostate Cancer

Por Adamo, Vincenzo, Noto, Laura, Franchina, Tindara, Chiofalo, Giuseppe, Picciotto, Maria, Toscano, Giuseppe, Caristi, Nicola
Publicado em 2012

Nab-paclitaxel and trastuzumab combination: a promising approach for neoadjuvant treatment in HER2-positive breast cancer

Por Ricciardi, Giuseppina Rosaria Rita, Franchina, Tindara, Russo, Alessandro, Schifano, Silvia, Ferraro, Giuseppa, Adamo, Vincenzo
Publicado no Onco Targets Ther (2016)

Long time response with chemotherapy in ROS1 NSCLC patient with unusual metastatic site

Por Franchina, Tindara, Russo, Alessandro, Ricciardi, Giuseppina Rosaria, Liguori, Giuseppina, Herberg, Astrid, Normanno, Nicola, Adamo, Vincenzo
Publicado no Cancer Biol Ther (2016)

Influence of EGFR mutational status on metastatic behavior in non squamous non small cell lung cancer

Por Russo, Alessandro, Franchina, Tindara, Ricciardi, Giuseppina Rosaria Rita, Fanizza, Caterina, Scimone, Antonino, Chiofalo, Giuseppe, Giordano, Antonio, Adamo, Vincenzo
Publicado no Oncotarget (2017)

Induction chemotherapy with paclitaxel and cisplatin to concurrent radiotherapy and weekly paclitaxel in the treatment of loco-regionally advanced, stage IV (M0), head and neck squ...

Por Pergolizzi Stefano, Santacaterina Anna, Adamo Barbara, Franchina Tindara, Denaro Nerina, Ferraro Pina, Ricciardi Giusy RR, Settineri Nicola, Adamo Vincenzo
Publicado em 2011-11-01

Induction chemotherapy with paclitaxel and cisplatin to concurrent radiotherapy and weekly paclitaxel in the treatment of loco-regionally advanced, stage IV (M0), head and neck squ...

Por Pergolizzi, Stefano, Santacaterina, Anna, Adamo, Barbara, Franchina, Tindara, Denaro, Nerina, Ferraro, Pina, Ricciardi, Giusy RR, Settineri, Nicola, Adamo, Vincenzo
Publicado em 2011

Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients

Por Ricciardi, Giuseppina Rosaria Rita, Adamo, Barbara, Ieni, Antonio, Licata, Luana, Cardia, Roberta, Ferraro, Giuseppa, Franchina, Tindara, Tuccari, Giovanni, Adamo, Vincenzo
Publicado no PLoS One (2015)

Correction: Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients

Por Ricciardi, Giuseppina Rosaria Rita, Adamo, Barbara, Ieni, Antonio, Licata, Luana, Cardia, Roberta, Ferraro, Giuseppa, Franchina, Tindara, Tuccari, Giovanni, Adamo, Vincenzo
Publicado no PLoS One (2015)

A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives

Por Russo, Alessandro, Franchina, Tindara, Rita Ricciardi, Giuseppina Rosaria, Picone, Antonio, Ferraro, Giuseppa, Zanghì, Mariangela, Toscano, Giuseppe, Giordano, Antonio, Adamo, Vincenzo
Publicado no Oncotarget (2015)

The comparison of outcomes from tyrosine kinase inhibitor monotherapy in second- or third-line for advanced non-small-cell lung cancer patients with wild-type or unknown EGFR statu...

Por Bronte, Giuseppe, Franchina, Tindara, Alù, Massimiliano, Sortino, Giovanni, Celesia, Claudia, Passiglia, Francesco, Savio, Giuseppina, Laudani, Agata, Russo, Alessandro, Picone, Antonio, Rizzo, Sergio, De Tursi, Michele, Gambale, Elisabetta, Bazan, Viviana, Natoli, Clara, Blasi, Livio, Adamo, Vincenzo, Russo, Antonio
Publicado no Oncotarget (2016)